Hyperammonemia is an adverse effect of valproate (VPA) treatment, In p
articular, transient hyperammonemia has been reported to occur in VPA-
treated patients after protein-rich meals, This phenomenon may occur s
econdary to a VPA-mediated carnitine insufficiency, We sought to confi
rm that protein ingestion would result in transient hyperammonemia and
to determine whether supplementation with L-carnitine mould prevent t
his effect, We studied the effect of consumption of a standardized pro
tein-rich meal (45 g protein) before (phase I) and after (phase II) ad
ministration of L-carnitine 50 mg/kg/day for 7 days in 11 epileptic ch
ildren (13.3 +/- 2.3 years of age) receiving VPA, Venous blood was obt
ained during fasting (baseline) and at 2 and 4 hours after the protein
-rich meal for analysis of ammonia (NH3), and VPA concentrations, Mean
VPA trough concentrations did not differ significantly at any time, A
fter protein ingestion, 2-hour NH3, concentration increased by 86% (P
<.05) from baseline in phase I as compared with a 38% increase in phas
e II, In both phases I and II, 4-hour NH3 concentrations decreased tow
ard baseline values, We conclude that (1) modest protein ingestion can
result in significant transient increases in NH3 in VPA-treated child
ren, (2) significant increases may occur in patients with normal fasti
ng NH3 concentrations, (3) these increases can be significantly attenu
ated by L-carnitine supplementation, and (4) these changes do not appe
ar to be related to changes in VPA concentration. (C) 1997 by Elsevier
Science Inc. All rights reserved.